Previous story: BD India and Dr Lal PathLabs launch best practices in phlebotomy to reduce lab errors and improve patient outcomes Next story: Hyderabad : The Cyient Foundation (the CSR arm of Cyient Ltd.) signed a memorandum of understanding ... APN News, 1 month ago
BD India and Dr Lal PathLabs launch COE in phlebotomy - Financial Express, 1 month ago
Dr Lal PathLabs & BD Collaborate to Drive Best Practices in Phlebotomy Healthcare Workers to Receive Certified Training on Safe Blood Collection Practices - Web Newswire, 1 month ago
1 images for "dr lal pathlabs"
By Biswarup Gooptu , ET Bureau | 11 May, 2015, 03.56AM IST Post a Comment NEW DELHI: Diagnostics and pathology services company Dr Lal PathLabs has mandated investment banks Kotak Investment Bank and Citi Investment Bank to lead its initial public offering, ...Economic Times, 2 months ago Kotak, Citi to lead Dr PathLabs public offer Economic Times, 2 months ago Kotak, Citi Investment Bank to lead PathLabs IPO Economic Times, 2 months ago
nd Mahajan Imaging, according to former athlete Gurbachan Singh Randhawa. Randhawa, India's legendary athlete, who finished fifth at the 1964 Tokyo Olympics, said that he convinced the two companies to offer discount to sportspersons. "I met Dr Arvind Lal of, ...Business Standard, 2 months ago
Manipal Education and Medical Group (MEMG), spearheaded by billionaire Ranjan Pai, is set to acquire Medall Healthcare, a southern diagnostics chain, in a deal valued at about Rs 1,000 crore ($180 million), two people directly familiar with the ...Asian Hospital & Healthcare Management, 1 week ago Manipal to buy diagnostic chain in Rs 1,000-crore deal Times of India, 1 week ago Manipal to buy diagnostic chain Medall in Rs 1,000-crore deal Economic Times, 1 week ago
In India, diagnostic tests and medicines cost a lot, and without proper access to the information on different diagnostic labs and hospitals, patients are often taken for a ride by unscrupulous doctors. What if patients had detailed information ...Yourstory.in, 2 weeks ago
MUMBAI/CHENNAI: The boardroom tussle in one of the country's leading diagnostics chain Metropolis Healthcare is possibly ending with estranged co-promoter GSK Velu selling his 37% stake to private equity giant Carlyle Group for more than Rs 900 ...Times of India, 3 weeks ago
BANGALORE: Private equity major TA Associates is leading a $500-million, or Rs 3,000 crore, acquisition of Atria Convergence Technologies (ACT), one of the country's leading high-speed broadband service providers headquartered in Bangalore. TA ...Times of India, 3 weeks ago US fund TA leads Rs 3,000 crore broadband co Atria buyout Economic Times, 3 weeks ago
The second edition of BW Healthcare Summit held in New Delhi on June 5 attracted major healthcare industry players. Dr Om Manchanda, chief executive officer of Dr Lal PathLabs, was among those who spoke at the event. He talked to Haider Ali Khan ...Businessworld India, 1 month ago
Given that Sebi is aware of CEO Velumani's issuing shares to employees and relatives, it would take some action against the company before approving the IPO document, say experts. The initial public offer (IPO) plan of Thyrocare Technologies Ltd, ...Livemint.com, 2 months ago Thyrocare Technologies' IPO plan hits Sebi roadblock [Mint, New Delhi] Bloomberg, 2 months ago
NEW DELHI: The Centre is set to announce a scheme for providing free diagnostic tests, including several blood tests, x-rays and advanced CT scans, for those visiting public health facilities. Private service providers will be roped in wherever required.Economic Times, 2 months ago
on your WebpageAdd Widget >Get your members hooked!